日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Re-Excision Rates in Breast-Conserving Surgery for Invasive Breast Cancer after Neoadjuvant Chemotherapy with and without the Use of a Radiopaque Tissue Transfer and X-ray System

新辅助化疗后,采用或不采用放射性不透光组织移植和X射线系统治疗浸润性乳腺癌保乳手术的再次切除率

Jamaris, Suniza; Akpolat-Basci, Leyla; Stephanou, Miltiades; Wetzig, Sarah; Cubuk, Yueksel; Gerharz, Johannes; Bittner, Ann-Kathrin; See, Mee Hoong; Liedtke, Cornelia; Kolberg, Hans-Christian

An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer-Experiences After 150 Cases

一项超低剂量(放射性活度低于20 MBq)的1天方案用于乳腺癌前哨淋巴结的检测——150例病例的经验

Kolberg, Hans-Christian; Afsah, Shabnam; Kuehn, Thorsten; Winzer, Ute; Akpolat-Basci, Leyla; Stephanou, Miltiades; Wetzig, Sarah; Hoffmann, Oliver; Liedtke, Cornelia

Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer

新辅助化疗后保乳手术中靶向术中肿瘤床强化放疗——激素受体阳性HER2阴性乳腺癌亚组分析

Kolberg, Hans-Christian; Lövey, György; Akpolat-Basci, Leyla; Stephanou, Miltiades; Fasching, Peter; Untch, Michael; Hoffmann, Oliver; Bulsara, Max; Vaidya, Jayant; Liedtke, Cornelia

Neoadjuvant Chemotherapy with Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results after a Median Follow-Up of over 4 Years

多西他赛、卡铂和每周曲妥珠单抗新辅助化疗对HER2阳性早期乳腺癌有效:中位随访4年以上的结果

Kolberg, Hans-Christian; Akpolat-Basci, Leyla; Stephanou, Miltiades; Aktas, Bahriye; Hannig, Carla Verena; Liedtke, Cornelia